Fennec Pharmaceuticals (FENC) Operating Expenses (2010 - 2025)

Fennec Pharmaceuticals' Operating Expenses history runs 16 years deep, the most recent figure standing at $16.3 million for Q4 2025.

• Quarterly Operating Expenses rose 84.34% year-over-year to $16.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $50.9 million (up 13.24% YoY) and the FY2025 annual result came in at $50.9 million, up 13.24% from the prior year.
• Operating Expenses was $16.3 million for Q4 2025 at Fennec Pharmaceuticals, up from $12.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $16.3 million in Q4 2025 and bottomed at -$5.0 million in Q2 2022.
• A 5-year average of $8.1 million and a median of $7.9 million in 2022 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses plunged 227.78% — and 2023, when it jumped 259.53%.
• Fennec Pharmaceuticals' Operating Expenses stood at $4.2 million in 2021, then surged by 80.27% to $7.6 million in 2022, then jumped by 52.33% to $11.6 million in 2023, then declined by 23.32% to $8.9 million in 2024, then jumped by 84.34% to $16.3 million in 2025.
• Business Quant data shows FENC's Operating Expenses at $16.3 million in Q4 2025, $12.7 million in Q3 2025, and $12.4 million in Q2 2025.